Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danilo Perrotti

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Blood|December 16, 2010
The PP2A inhibitor SET regulates granzyme B expression in human natural killer cellsRossana Trotta, David Ciarlariello, Jessica Dal Col, et al.
Blood|January 19, 2006
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cellsClara Guerzoni, Michela Bardini, Samanta A Mariani, et al.
Nature Genetics|December 26, 2001
BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2Danilo Perrotti, Vincenzo Cesi, Rossana Trotta, et al.
Blood|December 9, 2008
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cellsDon M Benson, Jianhua Yu, Brian Becknell, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse modelSukhinder K Sandhu, Stefano Volinia, Stefan Costinean, et al.
Blood|May 4, 2007
High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiationJi Suk Chang, Ramasamy Santhanam, Rossana Trotta, et al.
Blood|May 4, 2007
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemiaMichael A Caligiuri, Roger Briesewitz, Jianhua Yu, et al.
Haematologica|July 28, 2018
BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemiaKlara Srutova, Nikola Curik, Pavel Burda, et al.
Hematological Oncology|August 4, 2018
Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasmsTariq I Mughal, Thomas Lion, Omar Abdel-Wahab, et al.
Blood|September 1, 2007
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphomaQing Liu, Xiaobin Zhao, Frank Frissora, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Blood|December 16, 2010
The PP2A inhibitor SET regulates granzyme B expression in human natural killer cellsRossana Trotta, David Ciarlariello, Jessica Dal Col, et al.
Blood|January 19, 2006
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cellsClara Guerzoni, Michela Bardini, Samanta A Mariani, et al.
Nature Genetics|December 26, 2001
BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2Danilo Perrotti, Vincenzo Cesi, Rossana Trotta, et al.
Blood|December 9, 2008
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cellsDon M Benson, Jianhua Yu, Brian Becknell, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse modelSukhinder K Sandhu, Stefano Volinia, Stefan Costinean, et al.
Blood|May 4, 2007
High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiationJi Suk Chang, Ramasamy Santhanam, Rossana Trotta, et al.
Blood|May 4, 2007
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemiaMichael A Caligiuri, Roger Briesewitz, Jianhua Yu, et al.
Haematologica|July 28, 2018
BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemiaKlara Srutova, Nikola Curik, Pavel Burda, et al.
Hematological Oncology|August 4, 2018
Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasmsTariq I Mughal, Thomas Lion, Omar Abdel-Wahab, et al.
Blood|September 1, 2007
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphomaQing Liu, Xiaobin Zhao, Frank Frissora, et al.
Pageof 9